Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 713,000 | 1,807,000 | 1,102,000 | 1,451,000 | 1,105,000 |
| Receivables | 770,000 | 610,000 | 626,000 | 720,000 | 511,000 |
| Inventories | 1,472,000 | 1,352,000 | 1,404,000 | 1,099,000 | 939,000 |
| TOTAL | $3,026,000 | $3,835,000 | $3,214,000 | $3,345,000 | $2,633,000 |
| Non-Current Assets | |||||
| PPE Net | 3,183,000 | 3,216,000 | 3,171,000 | 3,154,000 | 3,474,000 |
| Investments And Advances | 152,000 | 158,000 | 175,000 | 169,000 | 167,000 |
| Intangibles | 49,000 | 105,000 | 115,000 | 108,000 | 167,000 |
| Other Non-Current Assets | 1,105,000 | 937,000 | 965,000 | 774,000 | 641,000 |
| TOTAL | $4,489,000 | $4,416,000 | $4,426,000 | $4,205,000 | $4,449,000 |
| Total Assets | $7,515,000 | $8,251,000 | $7,640,000 | $7,550,000 | $7,082,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 54,000 | 51,000 | 43,000 | 25,000 | 21,000 |
| Accounts payable and accrued liabilities | 1,142,000 | 1,159,000 | 1,233,000 | 1,162,000 | 844,000 |
| Other current liabilities | 214,000 | 218,000 | 315,000 | 346,000 | 202,000 |
| TOTAL | $1,803,000 | $2,486,000 | $1,891,000 | $1,858,000 | $1,442,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,054,000 | 3,987,000 | 3,590,000 | 3,724,000 | 4,005,000 |
| Other Non-Current Liabilities | 1,018,000 | 994,000 | 991,000 | 837,000 | 784,000 |
| TOTAL | $5,107,000 | $5,026,000 | $4,642,000 | $4,610,000 | $4,825,000 |
| Total Liabilities | $6,910,000 | $7,512,000 | $6,533,000 | $6,468,000 | $6,267,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,441 | 148,802 | 148,336 | 160,018 | 165,172 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 1,718,000 | 1,782,000 | 2,170,000 | 1,746,000 | 1,303,000 |
| Other shareholders' equity | -366,000 | -272,000 | -343,000 | -363,000 | -308,000 |
| TOTAL | $605,000 | $739,000 | $1,107,000 | $1,082,000 | $815,000 |
| Total Liabilities And Equity | $7,515,000 | $8,251,000 | $7,640,000 | $7,550,000 | $7,082,000 |